Fluticasone Propionate and Formoterol Fumarate Inhaler is a prescription combination therapy used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Fluticasone is a corticosteroid that reduces inflammation in the airways, while Formoterol is a long-acting beta-agonist that helps open the airways by relaxing the bronchial muscles. Together, they provide comprehensive and sustained control over respiratory symptoms.
This inhaler is not intended for acute symptom relief but is highly effective in long-term disease management, reducing hospitalizations and improving respiratory performance.
Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.
Corporate Office
Plot No. :46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India.
Manufacturing Unit
Village Kondi, Post Thana, District Solan, Baddi 173205 Himachal Pradesh, India.
